LabCorp to acquire Sequenom

Thursday, July 28, 2016

Laboratory Corporation of America Holdings (LabCorp), a healthcare diagnostics company, and Sequenom, a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.

[Read More]

Human Longevity acquires Cypher Genomics

Monday, November 30, 2015

San Diego’s Human Longevity Inc. (HLI), a genomics-based, technology-driven company, has acquired Cypher Genomics, a genome informatics company offering human genomic interpretation software solutions. The company has 14 employees who will join HLI, including Cypher CEO and co-founder Ashley Van Zeeland, Ph.D., who now is the head of HLI’s pediatric business. Financial details of the deal were not disclosed.

[Read More]

Arena President/CEO to step down

Wednesday, October 7, 2015

Arena Pharmaceuticals has announced that, at the request of the board of directors, company President and CEO Jack Lief has retired from the company, including the board. Dr. Harry Hixson, a director of Arena since 2004, has been appointed to serve as interim chief executive officer and interim principal financial officer. Arena will immediately initiate a search for a new chief executive.

[Read More]

Sequenom partners with LifeCodexx in first European commercial partnership

Thursday, August 11, 2011

Sequenom, a life sciences company providing innovative genetic analysis solutions, has partnered with LifeCodexx, a company focused on the development of clinically validated Next Generation Molecular Diagnostics, for the commercialization of prenatal laboratory testing services in Europe. The companies have agreed to collaborate in the development and launch of a trisomy 21 laboratory developed test and other aneuploidies testing in Germany, Austria, Switzerland, and Liechtenstein, with the potential for additional launches in other countries. 

[Read More]